Botched Abortions Injure Two Women on the Same Day at University of New Mexico Abortion Biz
Life News
Stay updated with breaking news from Ryan Residency Training. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The abortion industry is planning its next scheme to expand abortion pill access by suggesting pharmacists can prescribe the abortion pill, mifepristone. The move comes a year after the FDA gutted its REMS safety system for the abortion pill by announcing it would allow retail pharmacies to dispense the drug.
As abortion bans sweep the nation, OB-GYN residents rotate to abortion-supportive states to meet their program requirements
Abortion pill safety regulations created by the U.S. Food and Drug Administration (FDA), known as REMS, are the next target of the profitable abortion industry, which has historically bemoaned all regulations to protect women. The ultimate goal of these abortion advocates — many associated with Advancing New Standards in Reproductive Health (ANSIRH) — is to allow over-the-counter dispensing of the abortion pill.